Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 9.70M | $48.0M | 15.00% | +6.7K | 2026-06-30 |
| BlackRock, Inc. | 4.37M | $21.0M | 6.76% | +2.87M | 2026-06-30 |
| Sanofi | 2.71M | $13.0M | 4.19% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 2.29M | $11.0M | 3.54% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 1.94M | $9.0M | 2.99% | +106.9K | 2026-06-30 |
| Geode Capital Management, LLC | 1.37M | $6.0M | 2.12% | +732.8K | 2026-06-30 |
| State Street Corp | 1.00M | $4.0M | 1.55% | +733.5K | 2026-06-30 |
| DCF Advisers, LLC | 790.0K | $3.0M | 1.22% | +648.5K | 2026-06-30 |
| Marshall Wace, LLP | 731.9K | $3.0M | 1.13% | -1.26M | 2026-06-30 |
| Connor, Clark & Lunn Investment Management Ltd. | 601.3K | $3.0M | 0.93% | +200.9K | 2026-06-30 |
